We are proud to announce our partnership with Protege. AI companies can license Syndesis’s comprehensive clinical data through Protege’s secure, compliant data exchange platform, accelerating delivery of globally inclusive AI applications. Full story at:
https://t.co/QrSbJXvDOQ
We are proud to announce our partnership with Abu Dhabi Health Data Services. This collaboration uses Syndesis's data and ADHDS’s digital health platform to advance AI-powered genomic analytics, precision medicine, and drug discovery. https://t.co/DtZFrvF105
Syndesis Health is proud to announce we've joined the Atropos Evidence Network. The addition of our multi-country dataset of 35 million patients, better enables the Network as a platform for more personalized and effective treatments for patients. https://t.co/8beTUxJtl9
In our latest white paper, our chief innovation officer @zarkadakis explores how generative AI will usher in a new era for physicians and patients worldwide.
Visit our site to download today #artificialintelligence#aiinnovation#aiadvancements
https://t.co/hxEtouxvFx
🎉It is our great honour to bestow us with the Startup Pharma award at this year's #CPHIPharmaAwards!
We are expecting Pharma and Nutraceutical companies at our booth (3QS75) at the startup market in Hall 3 and at the Pitch Session at 11:30 am.
#CPHI#innovation
We are excited to share that Syndesis Health will be exhibiting at ISPOR Europe 2023 in Copenhagen from November 12-15.
#ISPOREurope#realworlddata#HEOR
Proud to partner with @InSyBio. Combining the global healthcare data within our Syntium platform with InSyBio’s biomarker discovery tools, we're poised to uncover breakthrough discoveries that will significantly improve patient outcomes. https://t.co/5NxpirrGBz
Syndesis Health is proud to announce our strategic partnership with @Prepaire_labs. Together we will aim to revolutionize global health outcomes and equity by providing cutting-edge genomic analytical services and gene editing tools. https://t.co/x34wXCn3Sh
Healthcare and life sciences are on a transformative journey towards a value-based, AI and data-driven future. However, to unlock its full potential, we must confront the challenges that lie ahead. Check out this white paper to learn more: https://t.co/ksTpL7x5Nu
In this latest blog post, George @zarkadakis, our Chief Innovation Officer, explores the potential benefits for precision medicine from the use of pangenome sequencing in tandem with diverse clinical data. Visit our website to read more. https://t.co/wifVNH0XR8
Our Chief Innovation Officer, @zarkadakis, writes about the diversity imbalance in real-world evidence, and the necessity for reliable channels that collect, aggregate, and analyze data on the journeys of all patients to improve global health outcomes. https://t.co/CILTnPi8eS
Welcome to the Syndesis Health Network, @fcardioinfantil! We look forward to working together to expand the potential for real-world data to enable research and treatments in the cardiovascular space. https://t.co/dw4tRWm1cg
We're pleased to share that Ambassador Dr. Mohammad Nafees Zakaria, Executive Director, @COMSATS_en, and Kamil Mehmood, Co-Founder & Director of Syndesis Health, signed an MoU for genomic sequencing programs. #healthequity#precisionmedicine https://t.co/mcWFpNoIzL
We are pleased to collaborate with @Comsats_en to advance healthcare for citizens and empower healthcare organizations across its 27 Member States. Read the full story: https://t.co/AK8WyoIMf9